Influence
November 8, 2025

Regenstrief researcher serves as visiting consultant with Emirates Health Services

Regenstrief Institute Research Scientist and Interim Director of the Indiana University Center for Aging Research at Regenstrief, Babar Khan, M.D., M.S., was invited by Emirates Health Services to be a visiting consultant at Ibrahim Bin Hamad Obaidullah Hospital.

During his visit, Dr. Khan conducted rounds and was actively involved in patient care, intensive care unit (ICU) procedures and implementation of care bundles. He streamlined assessments for pain, sedation, agitation and delirium, and provided hands-on training in bronchoscopy and mechanical ventilation practices. Additionally, he delivered two grand rounds focusing on delirium in the ICU and post-intensive care syndrome.

This visiting consultancy was coordinated through the IU Health Destination Services program.

Dr. Khan’s research focuses on delirium in the ICU and the long-term complications experienced by ICU survivors. He has developed and validated a novel tool to assess delirium severity and leads the Critical Care Recovery Center (CCRC), a unique post-ICU clinic that supports patients’ cognitive, physical, and psychological recovery while advancing evidence-based post-ICU research.

Babar Khan, M.D., M.S.
In addition to his role as interim director and research scientist with the Indiana University Center for Aging Research at Regenstrief Institute, Dr. Khan is also a professor of medicine and the Floyd and Reba Smith Professor in Respiratory Disease in the Division of Pulmonary and Critical Care Medicine at Indiana University School of Medicine. In January of 2024, he was appointed the first chief of the newly created Critical Care Section – Indiana Critical Care Management and Recovery Program in the IU Division of Pulmonary, Critical Care, Sleep and Occupational Medicine.

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher